Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent

International Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 82-93

  Teti, Anna ^a   Farina, Antonietta R ^a   Villanova, Ida ^a   Tiberio, Antonella ^a   Tacconelli, Antonella ^a   Sciortino, Giancarlo ^a   Chambers, Ann F ^b   Gulino, Alberto ^a   Mackay, Andrew R ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; CYTOCHALASIN B; DACTINOMYCIN; HERBIMYCIN; METALLOPROTEINASE; OSTEOPONTIN; SIALOPROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SHAPE; ENZYME ACTIVITY; GENE ACTIVATION; GIANT CELL TUMOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA SYNTHESIS;

CARCINOMA, GIANT CELL; CELL SIZE; ENZYME ACTIVATION; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; OLIGOPEPTIDES; OSTEOPONTIN; SIALOGLYCOPROTEINS; TUMOR CELLS, CULTURED;

EID: 0032479268     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980703)77:1<82::AID-IJC14>3.0.CO;2-B     Document Type: Article

References (52)

1. AIMES, R.T. and QUIGLEY, J.R, Matrix metalloproteinase 2 is an interstitial collagenase. J. biol. Chem., 270, 5872-5876 (1995).
2. AILENBERG, M. and SILVERMAN, M., Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase activator (MT-MMP). Biochem. J., 313, 879-884 (1996).
3. ATKINSON, S.J., CRABBE, T., COWELL, S., WARD, R.V., BUTLER, M.J., SATO, H., SEIKE, M., REYNOLDS, J.J. and MURPHY, G., Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. biol. Own., 270, 30479-30485 (1995).
4. AZZAM, H.S. and THOMPSON, E.W., Collagen induced activation of the Mr 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res., 52, 4540-4544 (1992).
5. BARON, R., Molecular mechanisms of bone resorption. Anat. Rec., 224, 317-324 (1989).
6. BROOKS, P.C., STROMBLAD, S., SANDERS. L.C., VON SCHALSCHA. T.L., AIMES, R.T., STETLER-STEVENSON, W.G., QUIGLEY, J.P. and CHERESH, D.A., Localisation of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αVβ3. Cell, 85, 683-693 (1996).
7. BROWN, P.D., KLEINER, D.E., UNSWORTH, E.J. and STETLER-STEVENSON, W.G., Cellular activation of the 72kDa type IV procollagenase/TIMP-2 complex. Kidney Int., 43, 163-170 (1993).
8. BUTLER, W.T., The nature and significance of osteopontin. Connective Tiss. Rex., 23, 123-136 (1989).
9. CHELLAIAH, M., FITZGERALD, C., FILARDO, E.J., CHERESH, D.A. and HRUSKA, K.A., Osteopontin activation of c-Src in human melanoma cells requires the cytoplasmic domain of the integrin V3 subunit. Endocrinology, 137, 2432-2440 (1996).
10. COTTAM, D.W. and REES, R.C., Regulation of matrix-metalloproteinases: their role in tumour invasion and metastasis., Int. J. Oncol., 2, 861-872 (1993).
11. CRABBE, T., SMITH, B., O'CONNEL, J. and DOCHERTY, A.J.P. Human progelatinase A can be activated by Matrilysin. FEBS Lett., 345, 14-16, (1994a)
12. CRABBE, T., O'CONNELL, J.P., SMITH, B.J. and DOCHERTY, A.J.P., Reciprocal matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A. Biochemistry, 33, 14419-14425 (1994b).
13. DAHLIN, D.C., CUPPS. R.E. and JOHNSON, E.W. JR., Giant cell tumor: a study of 195 cases. Cancer, 25, 1061-1070 (1970).
14. DELAISSE, J.-M. and VAES, G., In: B.R. Rifkin and C.V. Gay (eds.), Biology and physiology of the osteoclast, pp. 289-314, CRC Press, Boca Raton, FL (1993).
15. DENHARDT, D.T. and XIAOJIA, G., Osteopontin: a protein with diverse functions. FASEB. J., 7, 1475-1482 (1993).
16. FESTUCCIA, C., BOLOGNA, M., VICENTINI, C., TACCONELLI, A., MIANO, R., VIOLINI, S. and MACKAY, A.R., Increased matrix metalloproteinase-9 secretion in short term tissue cultures of prostatic tumor cells. Int. J. Cancer (Pred. Oncol.), 69, 1-8 (1996)
17. GEHRON ROBEY, P., The biochemistry of bone. Endocrinol. Metab. clin. North Amer., 18, 859-902 (1989).
18. GRANO, M., COLUCCI, S., DEBELLIS, M., ZIGRINO, P., ARGENTINO, L., ZAMBONIN, G., SERRA, M., SCOTLANDI, K., TETI, A. and ZAMBONINZALLONE, A., New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumours of bone. J. Bone Miner. Res., 9, 1013-1020 (1994b).
19. GRANO, M., ZIGRINO, P., COLUCCI, S., ZAMBONIN, G., TRUSOLINO, G., SERRA, M., BALDINI, N., TETI, A., MAKCHISIO, P.C. and ZAMBONIN-ZALLONE, A., Adhesion properties and integrin expression in cultured osteoclast-like cells. Exp. Cell Res., 212, 209-218 (1994a).
20. GRONOWICZ, G.A. and DEROME, M.E., Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralising organ culture system of foetal parietal bones. J. Bone Miner. Res., 9, 193-210 (1994).
21. HARRIS, E.D. JR., REYNOLDS, J.J. and WERB, Z., Cytochalasin B increases collagenase production by cells in vitro. Nature (Lond.), 257, 243-244 (1975).
22. HELFRICH, M.H., NESBITT, H.A., DOREY, E.L. and HORTON, M.A., Rat osteoclasts adhere to a wide range of ROD (Arg-Gly-Asp) peptide-containing proteins, including bone sialoprotein and fibronectin, via a beta 3 integrin. J. Bone Miner. Res., 7, 335-343 (1992).
23. HILL, P.A., DOCHERTY, A.J.P., BOTTOMLEY, K.M.K., O'CONNEL, J.P., MORPHY, R.J., REYNOLDS, J.J. and MEIKLE, M.C., Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J., 308, 167-175 (1995).
24. HORTON, M.A., DOREY, E.J., NESBITT, S.A., SAMANEN, J., ALI, F.E., STADEL, J.M., NICHOLS, A., GREIG, R. and HELFRICH, M.H., Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogues: a structure-function analysis. J. Bone Miner. Res., 8, 239-247 (1993).
25. HORTON, M.A., LEWIS, p., MCNULTY, K., PRINGLE, J.A.S. and CHAMBERS, T. J. Monoclonal antibodies to osteoclastomas (giant cell hone tumours): definition of osteoelast-specirk antigens. Cancer Res., 45, 663-5669 (1985).
26. HORION, M.A., TAYLOR, M.L., ARNETT, T.R. and HELFRICH. M.H., Arg-Gly-Asp (RGD) peptides and anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp. Cell Res., 195, 368-375 (1991).
27. HRUSKA, K.A., ROLNICK, F., HUSKEY, M., ALVAREZ, U. and CHERESH, D., Engagement of the osteoclast integrin αVβ3 by osteopontin stimulates phosphoinositol 3-hydroxyl kinase activity. Endocrinology 136, 984-2992 (1995).
28. KORNBERG, L., EARP, H.S., PARSONS, J., SCHALLER, M. and JULIANO, R.L., Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion associated tyrosine kinase. J. biol. Chem., 267, 23439-23442 (1992).
29. LOHI, J., LEHTI, K., WESTERMARCK, J., KAHARI, V.-M. and KESKI-OJA, J., Regulation of membrane-type metalloproteinase-l expression by growth factors and phorbol 12-myristrate 13-acetate. Europ. J. Biochem., 239, 239-247 (1996).
30. MACKAY, A.R., BALLIN, M., PELINA, M.D., FARINA, A.R., NASON, A.M. HARTZLER, J.L. and THORGEIRSSON, U.P., Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis, 12, 168-184 (1992).
31. MACKAY, A.R., HARTZLER, J.L., PELINA, M.D. and THORGEIRSSON, U.P., Studies on the ability of 65-kDa and 92kDa tumor cell gelatinases to degrade type IV collagen. J. biol. Chem., 265, 21929-21934 (1990).
32. MIYAUCHI, A., ALVAREZ, J., GREENFIELD, E.M., TETI, A., GRANO, M., COLUCCI, S., ZAMBONIN-ZALLONE, A., ROSE. F.P., TEITELBAUM, CHERESH, D. and HRUSKA, K.A., Recognition of osteopontin and related peptides by an αVβ3 integrin stimulates immediate cell signals in osteoclasts. J. biol. Chem., 266, 20369-20374 (1991).
33. OKADA, J., MORODOMI, T., ENGHILD, J.J., SUZUKI, K., YASUI A., NAKANISHI, I., SALVESEN, G. and NAGASE, H., Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymatic properties. Europ. J. Biochem., 194, 721-730 (1990).
34. OKADA, Y., NAKA, K., KAWAMURA, K., MATSUMOTO, T., NAKANISHI, I., FUJIMOTO, N., SATO, H. and SEIKE, M., Localisation of matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest., 72, 311-322 (1995).
35. OVERALL, C.M. and SODEK, J., Concanavalin A produces a matrix degrading phenotype in human fibroblasts. J. biol. Chem., 265, 21141-21151 (1990).
36. PANICCIA, R., COLUCCI, S., GRANO, M., SERRA, M., ZAMBONIN, A. and TETI, A., Immediate cell signal by bone related peptides in human osteoclast-like cells. Amer. J. Physiol. 265, C1289-C1297 (1993).
37. RAO, V.H., and 12 OTHERS, Expression of 72kDa and 92kDa type IV collagenases from human giant cell tumor of bone. Clin. exp. Metastasis, 13, 420-426 (1995).
38. REITH, A. and RUCKLIDGE, G.J., Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase. Biochem. biophys. Res. Comm., 186, 348-354 (1992).
39. ROODMAN, D.G., Advances in bone biology: the osteoclast. Endocrine Rev., 17, 308-332 (1996).
40. SATO, H., TAKINO, T., OKADA, Y., CAO, J., SHINAGAWA, A., YAMAMOTO, E. and SEIKE, M., A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370, 61-65 (1994).
41. SEFTOR, R.E., SEFTOR, E.A., GEHLSEN, K.R., STETLER-STEVENSON, W.G., BROWN, P.D., RUOSLAHTI, E. and HENDRIX, M.J., Role of the αVβ3 integrin in human melanoma cell invasion. Proc. nat. Acad. Sci. (Wash.), 89, 1557-1561 (1992).
42. STRONGIN, A.Y., COLLIER, I., BANNIKOV, G., MARMER, B.L., GRANT, G.A. and GOLDBERG, G.I., Mechanism of cell surface activation of 72kDa type IV collagenase. J. biol. Chem., 270, 5331-5338 (1995).
43. TIBERIO, A., FARINA, A.R., TACCONELLI, A., CAPPABIANCA, L., GULIN, A. and MACKAY, A.R., Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator. Int. J. Cancer, 73, 740-748 (1997).
44. VAN DER PLUIJM, G., MOUTHAAN, H., BAAS, C., DE GROOT, H., PAPAPOULOS, S. and LOWIK, C., Integrins and osteoclastic resorption in three bone organ cultures; differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation. J. Bone Miner. Res., 9, 1021-1028 (1994).
45. WARD, R.V., ATKINSON, S.J., REYNOLDS, J.J. and MURPHY, G., Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary tibroblasts. Biochem J., 304, 263-269 (1994).
46. WERB, Z., HEMBRY, R.M., MURPHY, G. and AGGELER, J., Commitment to expression of the metalloendopeptidases collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J. Cell Biol., 102, 697-702 (1986).
47. WERB, Z., TREMBLE, P.M., BEHRENDTSEN, O., CROWLEY, E. and DAMSKY, C.H., Signal transduction through the fibroncctin receptor induces collagenase and stromelysin gene expression. J. Cell Biol., 109, 877-889 (1989).
48. WOODS, A. and COUCHMAN, J.R., Protein kinase C involvement in focal adhesion formation. J. Cell Sci., 101, 77-290 (1992).
49. WUCHERPFENNIG, A.L., YI-PINO, L., STETLER-STEVENSON, W.G., ROSENBERG, A.E. and STASHENKO, P., Expression of 92kDa type IV collagenase B in human osteoclasts. J. Bone Miner. Res., 9, 549-556 (1994).
50. XUAN, J.-W., HOTA, C., SHIGEYAMA, Y., D'ERRICO, J.A., SOMERMAN. M.J. and CHAMBERS, A.F., Site directed mutagenesis of the arginine-glycine - aspartic acid sequence in osteopontin destroys cell adhesion and migration. J. Cell Biochem., 57, 680-690 (1995).
51. YU, M., SATO, H., SEIKI, M. and THOMPSON, E.W., Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res., 55, 3272-3277 (1995).
52. ZUCKER, S., CONNER, C., DIMASSMO, B.I., ENDE, H., DREWS, M., SEIKE, M. and BAHOU, W.F., Thrombin induces the activation of progelatinase a in vascular endothelial cells. J. biol. Chem., 270, 23730-23738 (1995).